Our latest news

SEDA announces £4m investment in new state-of-the-art facilities

SEDA named ‘Best CRO’ at OBN Awards 2021

Long Acting Injectables: Model Integrated Approaches for Bioequivalence

Movers and Shakers in BioBusiness 2021

Appointment of Paul Gellert

Bionow – 2021 Oncology Conference

Dissolution testing: Real-world evaluation of UV arch probes

SEDA Shortlisted as Finalist for Best CRO

AAPS PharmSci 360: Jake Dickinson presents non-linear IVIVC

Life Science Integrates Presentation with Paul Stott

SEDA’s Elen Roberts Accepted onto Master’s Course

SEDA’s cutting-edge Differential Scanning Calorimetry capabilities